The Prostate Health Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The global Prostate Health Market Report 2025 has shown a solid upward trend in recent years. The market size was $34.07 billion in 2024 and is projected to reach $37.34 billion in 2025. The market also exhibits a compound annual growth rate (CAGR) of 9.6%.
The global market for prostate health is predicted to rise to $53.25 billion by 2029, growing at a compound annual growth rate (CAGR) of 9.3%.
Download Your Free Sample of the 2025 Prostate Health Market Report and Uncover Key Trends Now!The key drivers in the prostate health market are:
• Growing adoption of precision medicine
• Increasing use of AI-driven diagnostics
• Expansion of targeted radiotherapies
• Rising demand for minimally invasive treatments
The prostate health market covered in this report is segmented –
1) By Disease Indication: Prostate Cancer, Benign Prostate Hyperplasia, Prostatitis
2) By Treatment: Hormonal Therapy, Chemotherapy, Surgical Treatments, Other Treatments
3) By Distribution Channel: E-Commerce Stores, Pharmacies, Other Distribution Channels
Subsegments:
1) By Prostate Cancer: Localized Prostate Cancer, Metastatic Prostate Cancer
2) By Benign Prostate Hyperplasia: Mild BPH, Moderate BPH, Severe BPH
3) By Prostatitis: Acute Bacterial Prostatitis, Chronic Bacterial Prostatitis, Chronic Prostatitis (Non-Bacterial)
The key trends in the prostate health market are:
• The adoption of precision medicine is increasingly shaping the future of the prostate health global market.
• There's a rising trend towards the use of AI-driven diagnostics in the market.
• Expansion of targeted radiotherapies is a noteworthy emerging trend in the industry.
• Real-time biomarker monitoring is another significant trend influencing the future of the market.
Major players in the prostate health market are:
• Pfizer Inc.
• Johnson & Johnson
• Siemens Healthineers AG
• Bayer AG
• Sanofi SA
• AstraZeneca PLC
• Abbott Laboratories
• Novartis AG
• Takeda Pharmaceutical Co Ltd
• Astellas Pharma Inc
• Genentech Inc.
• Teleflex Inc.
• Elekta AB
• Myriad Genetics Inc.
• Freenome
• Theragenics Corporation
• CureVac BV
• ArsenalBio
• Roivant Sciences
• Artera Inc.
• Veru Inc.
• HistoSonics Inc.
• Immunic Inc.
• Ezra
• Francis Medical
• CorTechs Labs
• Lucida Medical
• Serimmune Inc.
• Alessa Therapeutics.
North America was the largest region in the prostate health market in 2024